Influence of the Genetic Polymorphism in CYP2C9 on the Pharmacokinetics of (Delta Symbol should be added in place of ?) ?9-Tetrahydrocannabinol and Introduction of a New Pharmacokinetic Model

Presenting section:
Bernhard, Werner, Bern SWITZERLAND; Wolowich, William R., Fort Lauderdale FL; Sachs, Hans, Munich GERMANY; Kleine-Brueggeney, Maren, Bern SWITZERLAND; Greif, Robert, Bern SWITZERLAND; Theiler, Lorenz, Bern SWITZERLAND